A report in Alimentary Pharmacology and Therapeutics revealed that Liver stiffness and liver fat (steatosis) in chronic hepatitis C virus (HCV) infected patients improved considerably post-treatment with direct-acting antivirals (DAAs) resulting in sustained virological response (SVR). A fall in ALT levels and a rise in platelet count was observed six months after SVR.
The HCV RNA PCR test is a blood test that is advised by doctors in suspected patients to diagnose Hepatitis C infection. It calculates the hepatitis C viral load in the bloodstream. This article gives an insight into how the test functions and what the results signify.
Hepatitis C is a chronic, potentially fatal disease affecting the liver and is caused by a viral infection most frequently transmitted through large or repeated direct percutaneous exposures to infected blood. The two most common exposures associated with transmission of HCV are blood transfusion and injection drug use. It proves to be deadly because it develops silently i.e. it does not produce any marked signs and symptoms until it has progressed to an advanced stage.
Reports reveal that as many as 144,000 inmates of state prisons in the United States who have hepatitis C are not being given any kind of treatment. Corrections departments in every state were enquired about the number of inmates with hepatitis C, the treatment they were receiving, the drugs used for their treatment and also about policies that exist which concern inmates inflicted with the virus.
A research team led by the University of Cincinnati revealed that patients in need of kidney can opt for transplantation by safely receiving a kidney from an HCV-infected donor. This report was published online in Annals of Internal Medicine.
The hepatitis C antibody test detects antibodies for the hepatitis C virus in the blood. Antibodies in the body indicate that a person has been infected with the virus at some point. However, it does not always mean that they still have the virus.
Hepatitis C is caused by the Hepatitis C virus (HCV), which affects the liver. The World Health Organization (WHO) reported that around 399,000 people die every year due to Hepatitis C throughout the world. Hepatitis C leads to cirrhosis and liver cancer since it is diagnosed only at a late stage.
In response to the issue, the scientific team of Professor Yazdan Yazdanpanah's Inserm and Sylvie Deuffic-Burban created a mathematical model to estimate the efficiency and cost-effectiveness of varied screening strategies which includes universal screening.
A report was issued by the World Health Organization (WHO) recently that the number of people receiving hepatitis C cures was increased from 1 million in 2015 to 1.5 million in 2016. Previously, only a small number of countries took part in hepatitis C treatments.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.